文献速递淋巴瘤

细胞周期蛋白D1阴性套细胞淋巴瘤中CCND2和CCND3劫持免疫球蛋白轻链增强子

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.
PubMed 文献 · Blood · 2018-12-11

研究对56例细胞周期蛋白D1阴性/SOX11阳性套细胞淋巴瘤进行FISH、全基因组/外显子测序及基因表达和拷贝数分析,发现39例(70%)存在CCND2重排,并鉴定出CCND3附近免疫球蛋白κ(IGK)和λ(IGL)增强子劫持机制;4例无细胞周期蛋白D重排者显示CCNE1/CCNE2上调,具母细胞样形态、高基因组复杂性和CDKN2A/RB1缺失。

要点

  • 56例细胞周期蛋白D1阴性套细胞淋巴瘤中39例(70%)检出CCND2重排。
  • 全基因组/外显子测序发现CCND3附近IGK(2例)和IGL(1例)增强子劫持。
  • 特异性FISH探针额外检出10例隐匿性IGK与CCND3(6例)或CCND2(4例)并置。

核心结论

  • 几乎所有细胞周期蛋白D1阴性套细胞淋巴瘤携带与免疫球蛋白基因相关的CCND2/CCND3重排,包括一种新的IGK/L增强子劫持机制。
  • 一部分具有侵袭性特征的细胞周期蛋白D1/D2/D3阴性套细胞淋巴瘤存在细胞周期蛋白E失调。
  • 特异性FISH探针可能有助于细胞周期蛋白D1阴性套细胞淋巴瘤的分子识别和诊断。

研究设计与样本

  • 对56例细胞周期蛋白D1阴性/SOX11阳性套细胞淋巴瘤进行研究,采用荧光原位杂交(FISH)、全基因组/外显子测序、基因表达和拷贝数阵列分析。

主要发现

  • 断裂分离探针FISH在39例(70%)中鉴定出CCND2重排,未检出CCND3重排。
  • 对3例阴性病例行全基因组/外显子测序,鉴定出CCND3附近的IGK(n=2)和IGL(n=1)增强子劫持,与细胞周期蛋白D3过表达相关。
  • 使用包括IGK增强子区域在内的特异性FISH探针,在过表达相应细胞周期蛋白的套细胞淋巴瘤中额外检出10例隐匿性IGK与CCND3(6例)或CCND2(4例)并置。
  • 4例无细胞周期蛋白D重排的细胞周期蛋白D1阴性套细胞淋巴瘤显示CCNE1和CCNE2上调,这些病例具有母细胞样形态、高基因组复杂性以及CDKN2A和RB1缺失。
  • 细胞周期蛋白D1阴性套细胞淋巴瘤病例的基因组和基因表达谱与细胞周期蛋白D1阳性套细胞淋巴瘤无法区分。

关键数值与推荐

  • 56例细胞周期蛋白D1阴性/SOX11阳性套细胞淋巴瘤中,FISH检出CCND2重排39例(70%)。
  • 3例经全基因组/外显子测序的阴性病例中,IGK增强子劫持2例、IGL增强子劫持1例。
  • 特异性FISH探针额外检出隐匿性IGK并置10例:CCND3 6例、CCND2 4例。
  • 4例细胞周期蛋白D1阴性套细胞淋巴瘤缺乏细胞周期蛋白D重排,显示CCNE1和CCNE2上调。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32) translocation resulting in overexpression of cyclin D1. However, a small subset of cyclin D1- MCL has been recognized, and approximately one-half of them harbor CCND2 translocations while the primary event in cyclin D1-/D2- MCL remains elusive. To identify other potential mechanisms driving MCL pathogenesis, we investigated 56 cyclin D1-/SOX11+ MCL by fluorescence in situ hybridization (FISH), whole-genome/exome sequencing, and gene-expression and copy-number arrays. FISH with break-apart probes identified CCND2 rearrangements in 39 cases (70%) but not CCND3 rearrangements. We analyzed 3 of these negative cases by whole-genome/exome sequencing and identified IGK (n = 2) and IGL (n = 1) enhancer hijackings near CCND3 that were associated with cyclin D3 overexpression. By specific FISH probes, including the IGK enhancer region, we detected 10 additional cryptic IGK juxtapositions to CCND3 (6 cases) and CCND2 (4 cases) in MCL that overexpressed, respectively, these cyclins. A minor subset of 4 cyclin D1- MCL cases lacked cyclin D rearrangements and showed upregulation of CCNE1 and CCNE2. These cases had blastoid morphology, high genomic complexity, and CDKN2A and RB1 deletions. Both genomic and gene-expression profiles of cyclin D1- MCL cases were indistinguishable from cyclin D1+ MCL. In conclusion, virtually all cyclin D1- MCLs carry CCND2/CCND3 rearrangements with immunoglobulin genes, including a novel IGK/L enhancer hijacking mechanism. A subset of cyclin D1-/D2-/D3- MCL with aggressive features has cyclin E dysregulation. Specific FISH probes may allow the molecular identification and diagnosis of cyclin D1- MCL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Martín-Garcia D, Navarro A, Valdés-Mas R, et al. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. Blood. 2018. PMID: 30538135. doi:10.1182/blood-2018-07-862151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。